Published in Neurology on September 04, 2007
The pharmacokinetics, CNS pharmacodynamics and adverse event profile of brivaracetam after multiple increasing oral doses in healthy men. Br J Clin Pharmacol (2008) 0.85
Extended-release formulations of antiepileptic drugs: rationale and comparative value. Epilepsy Curr (2009) 0.84
Brivaracetam differentially affects voltage-gated sodium currents without impairing sustained repetitive firing in neurons. CNS Neurosci Ther (2014) 0.82
Effects of marketed antiepileptic drugs and placebo in the human photosensitivity screening protocol. Neurotherapeutics (2014) 0.77
Kv7 potassium channel activation with ICA-105665 reduces photoparoxysmal EEG responses in patients with epilepsy. Epilepsia (2013) 0.77
Brivaracetam as adjunctive therapy for the treatment of partial-onset seizures in patients with epilepsy: the current evidence base. Ther Adv Neurol Disord (2016) 0.75
Profile of brivaracetam and its potential in the treatment of epilepsy. Neuropsychiatr Dis Treat (2015) 0.75
Effects of antiepileptic drugs on motor cortex excitability in humans: a transcranial magnetic stimulation study. Ann Neurol (1996) 4.02
The ecological determinants of reinforcement in the rat. Physiol Behav (1973) 3.66
Semiological seizure classification. Epilepsia (1998) 2.96
The effect of lorazepam on the motor cortical excitability in man. Exp Brain Res (1996) 2.92
Hashimoto's encephalitis as a differential diagnosis of Creutzfeldt-Jakob disease. J Neurol Neurosurg Psychiatry (1999) 2.55
Energy expended playing Xbox Kinect™ and Wii™ games: a preliminary study comparing single and multiplayer modes. Physiotherapy (2012) 2.34
Epileptic negative myoclonus. Neurology (1993) 2.15
Defective neurogenesis in citron kinase knockout mice by altered cytokinesis and massive apoptosis. Neuron (2000) 2.04
Corticotropin-releasing hormone-induced seizures in infant rats originate in the amygdala. Ann Neurol (1992) 1.95
Ecological determinants of reinforcement in the guinea pig. Physiol Behav (1974) 1.84
The pharmacokinetics of oxybutynin in man. Eur J Clin Pharmacol (1988) 1.83
'De novo' absence status of late onset: report of 11 cases. Neurology (1992) 1.79
Reliability of self-monitoring of blood glucose by CSII-treated patients with type I diabetes. Diabetes Care (1989) 1.78
Plant cyclins: a unified nomenclature for plant A-, B- and D-type cyclins based on sequence organization. Plant Mol Biol (1996) 1.73
How to improve the clinical diagnosis of Creutzfeldt-Jakob disease. Brain (1999) 1.71
Entamoeba histolytica and Entamoeba dispar: differences in numbers and expression of cysteine proteinase genes. Mol Microbiol (1996) 1.59
Creutzfeldt-Jakob disease in Germany: a prospective 12-year surveillance. Brain (2007) 1.56
Nonconvulsive status epilepticus in two patients receiving tiagabine treatment. Epilepsia (1998) 1.55
Unsuspected atypical hemispheric dominance for language as determined by fMRI. Epilepsia (2001) 1.52
Current clinical diagnosis in Creutzfeldt-Jakob disease: identification of uncommon variants. Ann Neurol (2000) 1.49
Psychogenic aphonia: spectacular recovery after motor cortex transcranial magnetic stimulation. J Neurol Neurosurg Psychiatry (2009) 1.47
Role of pontine nuclei damage in smooth pursuit impairment of progressive supranuclear palsy: a clinical-pathologic study. Neurology (1994) 1.46
Cell wall-associated protein antigens of Streptococcus salivarius: purification, properties, and function in adherence. Infect Immun (1982) 1.44
Surface EMG and myosonography in the detection of fasciculations: a comparative study. J Neuroimaging (1998) 1.40
Clinical and EEG findings in complex partial status epilepticus with tiagabine. Seizure (1999) 1.39
Patients with Alzheimer's disease and dementia with Lewy bodies mistaken for Creutzfeldt-Jakob disease. J Neurol Neurosurg Psychiatry (2001) 1.39
MsERK1: a mitogen-activated protein kinase from a flowering plant. Plant Cell (1993) 1.38
Skin wounds and severed nerves heal normally in mice lacking tenascin-C. Proc Natl Acad Sci U S A (1996) 1.38
Accuracy of implant placement based on pre-surgical planning of three-dimensional cone-beam images: a pilot study. J Clin Periodontol (2007) 1.38
Defective recovery and severe renal damage after acute hemolysis in hemopexin-deficient mice. Blood (1999) 1.38
The Heidenhain variant of Creutzfeldt-Jakob disease. Arch Neurol (1999) 1.37
Lamotrigine and seizure aggravation in severe myoclonic epilepsy. Epilepsia (1998) 1.37
Reinforcing properties of spontaneous activity in the rat. J Comp Physiol Psychol (1971) 1.36
Brain abscesses in neonates. A study of 30 cases. J Neurosurg (1988) 1.35
Acute systemic inflammation up-regulates secretory sphingomyelinase in vivo: a possible link between inflammatory cytokines and atherogenesis. Proc Natl Acad Sci U S A (2000) 1.34
Basal ganglia involvement in rotational seizures. Epileptic Disord (1999) 1.33
Effort as determinant of intake and patterns of drinking in the guinea pig. Physiol Behav (1974) 1.29
Phosphoinositide 3-kinase gamma: a key modulator in inflammation and allergy. Biochem Soc Trans (2003) 1.27
Stenosis of the aqueduct of Sylvius. Etiology and treatment. J Neurosurg Sci (1986) 1.27
Distinct roles of the adaptor protein Shc and focal adhesion kinase in integrin signaling to ERK. J Biol Chem (2000) 1.27
Dopaminergic and cholinergic lesions in progressive supranuclear palsy. Ann Neurol (1985) 1.26
Nitazoxanide: pharmacokinetics and metabolism in man. Int J Clin Pharmacol Ther (2000) 1.25
Contralateral disappearance of parkinsonian signs after subthalamic hematoma. Neurology (1992) 1.23
Melusin is a new muscle-specific interactor for beta(1) integrin cytoplasmic domain. J Biol Chem (1999) 1.22
Altered susceptibility to collagen-induced arthritis in transgenic mice with aberrant expression of interleukin-1 receptor antagonist. Arthritis Rheum (1998) 1.22
Normal skeletal development of mice lacking matrilin 1: redundant function of matrilins in cartilage? Mol Cell Biol (1999) 1.21
Genetic analyses of integrin function in mice. Curr Opin Cell Biol (1996) 1.21
Exchange of amino acids by muscle and liver in sepsis. Arch Surg (1983) 1.21
Linkage of benign familial infantile convulsions to chromosome 16p12-q12 suggests allelism to the infantile convulsions and choreoathetosis syndrome. Am J Hum Genet (2001) 1.19
Genetic analysis of beta1 integrin function: confirmed, new and revised roles for a crucial family of cell adhesion molecules. J Cell Sci (1997) 1.19
Penetrating esophageal injuries: multicenter study of the American Association for the Surgery of Trauma. J Trauma (2001) 1.19
Likert pain score modeling: a Markov integer model and an autoregressive continuous model. Clin Pharmacol Ther (2012) 1.18
Medical outreach to Armenia by telemedicine linkage. J Med Syst (1996) 1.18
An immunohistochemical study of the distribution of brain-derived neurotrophic factor in the adult human brain, with particular reference to Alzheimer's disease. Neuroscience (1999) 1.17
Lipids on the move: phosphoinositide 3-kinases in leukocyte function. Immunol Today (2000) 1.17
Septic lung and shock lung in man. Ann Surg (1975) 1.15
alpha2-chimaerin, a Cdc42/Rac1 regulator, is selectively expressed in the rat embryonic nervous system and is involved in neuritogenesis in N1E-115 neuroblastoma cells. J Neurosci (2001) 1.15
Epilepsy in the tropics: II. Clinical presentations, pathophysiology, immunologic diagnosis, economics, and therapy. Epilepsia (1996) 1.15
Diagnostic of precipitant for biomacromolecule crystallization by quasi-elastic light-scattering. J Mol Biol (1990) 1.14
A double-blind controlled clinical trial: oxcarbazepine versus sodium valproate in adults with newly diagnosed epilepsy. Epilepsy Res (1997) 1.12
Pilar sheath acanthoma. Arch Dermatol (1987) 1.11
Integrin function and regulation in development. Int J Dev Biol (2000) 1.09
Effects of levetiracetam, a novel antiepileptic drug, on convulsant activity in two genetic rat models of epilepsy. Epilepsy Res (1995) 1.09
Blood insulin responses to blood glucose levels in high output sepsis and spetic shock. Am J Surg (1978) 1.06
Determination of hemisphere dominance for language: comparison of frontal and temporal fMRI activation with intracarotid amytal testing. Neuroradiology (2002) 1.05
Familial cortical myoclonic tremor with epilepsy: the third locus (FCMTE3) maps to 5p. Neurology (2010) 1.05
Reduced expression of brain-derived neurotrophic factor protein in Parkinson's disease substantia nigra. Neuroreport (1999) 1.05
EEG criteria predictive of complicated evolution in idiopathic rolandic epilepsy. Neurology (2001) 1.05
Clinical factors of drug resistance in juvenile myoclonic epilepsy. J Neurol Neurosurg Psychiatry (2001) 1.05
Mosaic mutations of the LIS1 gene cause subcortical band heterotopia. Neurology (2003) 1.04
Adult myoclonic epilepsy: a distinct syndrome of idiopathic generalized epilepsy. Neurology (2000) 1.04
Cerebral glucose utilization during sleep in Landau-Kleffner syndrome: a PET study. Epilepsia (1991) 1.04
Role of Listeria monocytogenes exotoxins listeriolysin and phosphatidylinositol-specific phospholipase C in activation of human neutrophils. Infect Immun (1999) 1.03
A pharmacodynamic Markov mixed-effects model for determining the effect of exposure to certolizumab pegol on the ACR20 score in patients with rheumatoid arthritis. Clin Pharmacol Ther (2009) 1.02
Heterogeneous intracellular localization and expression of ataxin-3. Neurobiol Dis (1998) 1.02
Low-frequency repetitive transcranial magnetic stimulation improves intractable epilepsy. Lancet (1999) 1.02
Assessing homeless population size through the use of emergency and transitional shelter services in 1998: results from the analysis of administrative data from nine US jurisdictions. Public Health Rep (2002) 1.02
Neurocan is dispensable for brain development. Mol Cell Biol (2001) 1.02
gamma-Hydroxybutyric acid induced spike and wave discharges in rats: relation to high-affinity [3H]gamma-hydroxybutyric acid binding sites in the thalamus and cortex. Neuroscience (1993) 1.01
Subthalamotomy in parkinsonian monkeys. Behavioural and biochemical analysis. Brain (1996) 1.00
Crosslinking of alpha-synuclein by advanced glycation endproducts--an early pathophysiological step in Lewy body formation? J Chem Neuroanat (2000) 1.00
Survival from sepsis. The significance of altered protein metabolism regulated by proteolysis inducing factor, the circulating cleavage product of interleukin-1. Ann Surg (1985) 1.00
Platelet activation by von Willebrand factor requires coordinated signaling through thromboxane A2 and Fc gamma IIA receptor. J Biol Chem (2001) 1.00
Multilobar polymicrogyria, intractable drop attack seizures, and sleep-related electrical status epilepticus. Neurology (1998) 1.00
A new epileptic seizure classification based exclusively on ictal semiology. Acta Neurol Scand (1999) 0.99
Identical genetic locus for Baltic and Mediterranean myoclonus. Lancet (1992) 0.99
Expression of beta 1 integrin complexes on the surface of unfertilized mouse oocyte. Development (1993) 0.98
Recurrence of the T666M calcium channel CACNA1A gene mutation in familial hemiplegic migraine with progressive cerebellar ataxia. Am J Hum Genet (1999) 0.98
Experimental and clinical studies with diazoxide. Ann N Y Acad Sci (1968) 0.98
Factors influencing surgical outcome in patients with focal cortical dysplasia. J Neurol Neurosurg Psychiatry (2007) 0.98
S 17092-1, a highly potent, specific and cell permeant inhibitor of human proline endopeptidase. Biochem Biophys Res Commun (1999) 0.97
Synaptic plasticity in the caudate nucleus of patients with Parkinson's disease. Neurodegeneration (1996) 0.97
Short-interval amygdala kindling in neonatal rats. Brain Res Dev Brain Res (1993) 0.97
[RU 28965, a new semi-synthetic macrolide. Bioavailability and pharmacokinetic profile after oral administration]. Pathol Biol (Paris) (1985) 0.97
Cognitive development in benign focal epilepsies of childhood. Dev Neurosci (1999) 0.96
Dynamic induction of the long pentraxin PTX3 in the CNS after limbic seizures: evidence for a protective role in seizure-induced neurodegeneration. Neuroscience (2001) 0.95
Dominant partial epilepsies. A clinical, electrophysiological and genetic study of 19 European families. Brain (2000) 0.95
Strong absorption and selective emission from engineered metals with dielectric coatings. Opt Express (2013) 0.95
Seizures in Klinefelter's syndrome. Pediatr Neurol (1998) 0.95